Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (282) 282
life sciences & biomedicine (275) 275
humans (203) 203
microbiology (147) 147
infectious diseases (127) 127
mycology (82) 82
biological and medical sciences (74) 74
antifungal agents - pharmacology (70) 70
medical sciences (63) 63
pharmacology & pharmacy (63) 63
mycoses (62) 62
female (59) 59
immunology (58) 58
male (56) 56
antifungal agents (50) 50
aspergillosis (50) 50
aspergillus (47) 47
fungi (46) 46
middle aged (43) 43
antifungal agents - therapeutic use (42) 42
aspergillus - drug effects (40) 40
microbial sensitivity tests (40) 40
adult (37) 37
animals (34) 34
candida (34) 34
pharmacology. drug treatments (33) 33
aspergillosis - microbiology (32) 32
health aspects (31) 31
antibiotics. antiinfectious agents. antiparasitic agents (30) 30
dermatology (30) 30
drug resistance, fungal (30) 30
epidemiology (30) 30
fundamental and applied biological sciences. psychology (30) 30
bacterial infections and mycoses (28) 28
fungal infections (28) 28
amphotericin b (27) 27
aspergillosis - drug therapy (26) 26
research (26) 26
voriconazole (26) 26
aged (25) 25
aspergillus - isolation & purification (25) 25
susceptibility (25) 25
candida - drug effects (24) 24
immunocompromised host (24) 24
hematology (23) 23
life sciences (23) 23
mycoses - microbiology (22) 22
risk factors (22) 22
virulence (22) 22
amphotericin b - pharmacology (21) 21
infections (21) 21
microbial sensitivity tests - methods (21) 21
skin and connective tissue diseases (21) 21
diagnosis (20) 20
analysis (19) 19
drug resistance (19) 19
infection (19) 19
medical colleges (19) 19
mucormycosis (19) 19
polymerase chain reaction (19) 19
antifungal agents - administration & dosage (18) 18
mortality (18) 18
triazoles - pharmacology (18) 18
aspergillus fumigatus (17) 17
candida - isolation & purification (17) 17
care and treatment (17) 17
medicine & public health (17) 17
sensitivity and specificity (17) 17
abridged index medicus (16) 16
mice (16) 16
azoles (15) 15
innate immunity (15) 15
internal medicine (15) 15
mycoses - drug therapy (15) 15
posaconazole (15) 15
young adult (15) 15
adolescent (14) 14
aspergillus fumigatus - drug effects (14) 14
candidemia (14) 14
complement (14) 14
echinocandins - pharmacology (14) 14
fluconazole (14) 14
invasive aspergillosis (14) 14
prospective studies (14) 14
transplantation (14) 14
aspergillosis - diagnosis (13) 13
aspergillus - genetics (13) 13
candidiasis (13) 13
dna, fungal - genetics (13) 13
europe (13) 13
human mycoses (13) 13
infectious disease (13) 13
miscellaneous (13) 13
patients (13) 13
platelets (13) 13
treatment outcome (13) 13
amphotericin b - therapeutic use (12) 12
aspergillus - growth & development (12) 12
austria (12) 12
candidiasis - drug therapy (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing
by Cornelia Lass-Flörl and Astrid Mayr and Susanne Perkhofer and Guido Hinterberger and Johann Hausdorfer and Cornelia Speth and Manfred Fille
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2008, Volume 52, Issue 10, pp. 3637 - 3641
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antifungal agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antifungal Agents - pharmacology | Guidelines as Topic | Fungi - drug effects | Europe | Humans | Amphotericin B - pharmacology | Fungi - isolation & purification | Mycoses - microbiology | Yeasts - drug effects | Candida - isolation & purification | Aspergillus - drug effects | Opportunistic Infections - microbiology | Triazoles - pharmacology | Microbial Sensitivity Tests - standards | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Aspergillus - isolation & purification | Candida - drug effects | Yeasts - isolation & purification | Drug Resistance, Fungal | Microbial Sensitivity Tests - methods | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Human Protothecosis
by Cornelia Lass-Flörl and Astrid Mayr
Clinical Microbiology Reviews, ISSN 0893-8512, 04/2007, Volume 20, Issue 2, pp. 230 - 242
Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Parasitic diseases | Biological and medical sciences | Medical sciences | Antifungal Agents - pharmacology | Prototheca - physiology | Infection - drug therapy | Humans | Prototheca - classification | Phylogeny | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Infection - epidemiology | Prototheca - drug effects | Infection - diagnosis | Anti-Bacterial Agents - pharmacology | Index Medicus | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
by Tissot, Frederic and Agrawal, Samir and Pagano, Livio and Petrikkos, Georgios and Groll, Andreas H and Skiada, Anna and Lass-Flörl, Cornelia and Calandra, Thierry and Viscoli, Claudio and Herbrecht, Raoul
Haematologica (Roma), ISSN 0390-6078, 02/2017, Volume 102, Issue 3, pp. 433 - 444
Life Sciences & Biomedicine | Hematology | Science & Technology | Aspergillosis - therapy | Candidiasis, Invasive - therapy | Mucormycosis - diagnosis | Europe | Humans | Leukemia - therapy | Aspergillosis - diagnosis | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Mucormycosis - therapy | Antifungal Agents - therapeutic use | Candidiasis, Invasive - diagnosis | Aspergillosis - etiology | Leukemia - complications | Hematopoietic Stem Cell Transplantation - adverse effects | Disease Management | Mucormycosis - etiology | Candidiasis, Invasive - etiology | Index Medicus | Guideline
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antifungal drug resistance among Candida species: mechanisms and clinical impact
by Sanguinetti, Maurizio and Posteraro, Brunella and Lass‐Flörl, Cornelia
Mycoses, ISSN 0933-7407, 06/2015, Volume 58, Issue 2, pp. 2 - 13
echinocandins | susceptibility testing | Antifungal drug resistance | azoles | Candida | Echinocandins | Azoles | Susceptibility testing | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Antifungal Agents - pharmacology | Humans | Candida - drug effects | Azoles - pharmacology | Candidiasis - microbiology | Candida - isolation & purification | Drug Resistance, Fungal | Echinocandins - pharmacology | Drug resistance | Drug therapy | Antifungal agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)
by Arendrup, Maiken C and Cuenca-Estrella, Manuel and Lass-Flörl, Cornelia and Hope, William and the EUCAST-AFST and EUCAST-AFST
Clinical microbiology and infection, ISSN 1198-743X, 07/2012, Volume 18, Issue 7, pp. E246 - E247
susceptibility testing | EUCAST | Candida | Cryptococcus | antifungals | yeast | minimum inhibitory concentration | Antifungals | Yeast | Minimum inhibitory concentration | Susceptibility testing | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Microbial Sensitivity Tests - standards | Time Factors | Solvents - chemistry | Europe | Humans | Antifungal Agents - chemistry | Yeasts - drug effects | Microbial Sensitivity Tests - methods | Freezing | Solvents | fluconazole | Antifungal agents | Caspofungin | Quality control | echinocandins | Antimicrobial agents | Shelf life | micafungin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Identification of Aspergillus fumigatus Surface Components That Mediate Interaction of Conidia and Hyphae With Human Platelets
by Günter Rambach and Gerhard Blum and Jean-Paul Latge and Thierry Fontaine and Thorsten Heinekamp and Magdalena Hagleitner and Hanna Jeckström and Günter Weigel and Philipp Würtinger and Kristian Pfaller and Sven Krappmann and Jürgen Löffler and Cornelia Lass-Flörl and Cornelia Speth
The Journal of infectious diseases, ISSN 0022-1899, 10/2015, Volume 212, Issue 7, pp. 1140 - 1149
FUNGI | hydrophobin | innate immunity | melanin | fungal surface | Invasive aspergillosis | Aspergillus fumigatus | galactosaminogalactan | platelets | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hyphae - chemistry | Humans | Melanins - immunology | Polysaccharides - immunology | Virulence Factors - immunology | Aspergillus fumigatus - chemistry | Spores, Fungal - physiology | Immunity, Innate - immunology | Spores, Fungal - chemistry | Flow Cytometry | Fungal Proteins - immunology | Platelet Activation | Blood Platelets - ultrastructure | Aspergillosis - microbiology | Aspergillus fumigatus - physiology | Blood Platelets - microbiology | Chitin - immunology | beta-Glucans - immunology | Antigens, Surface - immunology | Hyphae - physiology | Aspergillus | Research | Hydrophobins | Hyphae | Index Medicus | Abridged Index Medicus | Mycology | Blood Platelets | Melanins | Fungal Proteins | Chitin | Immunity, Innate | Virulence Factors | Life Sciences | Microbiology and Parasitology | Polysaccharides | Spores, Fungal | Aspergillosis | Antigens, Surface | beta-Glucans
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
by Klaus Leth Mortensen and Emilia Mellado and Cornelia Lass-Flörl and Juan Luis Rodriguez-Tudela and Helle Krogh Johansen and Maiken Cavling Arendrup
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2010, Volume 54, Issue 11, pp. 4545 - 4549
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Pyrimidines - pharmacology | Azoles - pharmacology | Itraconazole - pharmacology | Spain | Microbial Sensitivity Tests | Triazoles - pharmacology | Austria | Environmental Microbiology | Aspergillus fumigatus - isolation & purification | Voriconazole | Denmark | Drug Resistance, Fungal | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Changes in the epidemiological landscape of invasive mould infections and disease
by Lass-Flörl, Cornelia and Cuenca-Estrella, Manuel
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 03/2017, Volume 72, Issue suppl_1, pp. i5 - i11
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aspergillus fumigatus - drug effects | Mucormycosis - epidemiology | Fusariosis - epidemiology | Humans | Scedosporium - drug effects | Drug Resistance, Fungal - physiology | Mucorales - drug effects | Fusarium - drug effects | Aspergillosis - epidemiology | Antifungal Agents - therapeutic use | Invasive Fungal Infections - drug therapy | Mucormycosis - microbiology | Aspergillosis - microbiology | Fusariosis - drug therapy | Immunocompromised Host | Mucormycosis - drug therapy | Invasive Fungal Infections - microbiology | Aspergillosis - drug therapy | Fusariosis - microbiology | Invasive Fungal Infections - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together
by Hoenigl, Martin and Gangneux, Jean‐Pierre and Segal, Esther and Alanio, Alexandre and Chakrabarti, Arunaloke and Chen, Sharon C.‐A and Govender, Nelesh and Hagen, Ferry and Klimko, Nikolaj and Meis, Jacques F and Pasqualotto, Alessandro C and Seidel, Danila and Walsh, Thomas J and Lagrou, Katrien and Lass‐Flörl, Cornelia and Cornely, Oliver A and ECMM and European Confederation of Medical Mycology (ECMM) and the European Confederation of Medical Mycology (ECMM)
Mycoses, ISSN 0933-7407, 11/2018, Volume 61, Issue 11, pp. 885 - 894
Aspergillus | epidemiology | mucormycoses | low resource | Candida | aspergillosis | guideline | recommendation | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Leadership | Fungi - drug effects | Europe | Humans | Fungi - isolation & purification | Mycoses - microbiology | Patient Care - standards | Fungi - genetics | Fungi - physiology | Mycoses - drug therapy | Mycoses - diagnosis | Biomedical Research | Practice Guidelines as Topic | Medical research | Drug resistance in microorganisms | Care and treatment | Mycoses | Medicine, Experimental | Patients | Epidemiology | Mucormycosis | Multidrug resistance | Antifungal agents | Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights